R. Kelly

发表

Establishing biomarkers of oxidative stress: the measurement of hydrogen peroxide in human urine.

B. Halliwell, L. Long, Tsin Pinn Yee, 2004, Current medicinal chemistry.

Polar lipid derangements in type 2 diabetes mellitus: potential pathological relevance of fatty acyl heterogeneity in sphingolipids

M. Wenk, G. Shui, R. Kelly, 2013, Metabolomics.

Pharmacokinetic and Pharmacodynamic Effects of Prasugrel in Healthy Korean Males

Kyung-Woo Park, K. Yu, R. Kelly, 2013, Journal of cardiovascular pharmacology.

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies

T. Hardy, H. Fu, D. Moller, 2015, Diabetes Care.

Once‐weekly dulaglutide 1.5 mg restores insulin secretion in response to intravenous glucose infusion

C. Kapitza, R. Kelly, A. de la Peña, 2017, Diabetes, obesity & metabolism.

Limited antioxidant effect after consumption of a single dose of tomato sauce by young males, despite a rise in plasma lycopene

B. Halliwell, C. Ong, J. Gruber, 2009, Free radical research.

Response to Comment on Kazda et al. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241–1249

T. Hardy, H. Fu, D. Moller, 2016, Diabetes Care.

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes

H. Fu, R. Kelly, W. Landschulz, 2015 .

A Randomized , Double-Blind , Placebo-Controlled Phase 2 Study of the Glucagon Receptor Antagonist LY 2409021 in Patients With Type 2 Diabetes

H. Fu, R. Kelly, W. Landschulz, 2015 .

Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.

K. Winters, Lei-Bin Shen, R. Kelly, 2012, British journal of clinical pharmacology.

Cautions in the use of biomarkers of oxidative damage; the vascular and antioxidant effects of dark soy sauce in humans.

B. Halliwell, A. Jenner, L. Long, 2006, Biochemical and biophysical research communications.

Lack of effect of acute oral ingestion of vitamin C on oxidative stress, arterial stiffness or blood pressure in healthy subjects

B. Halliwell, R. Kelly, C. J. Lee, 2008, Free radical research.

Short‐term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes

H. Fu, R. Kelly, M. Prince, 2015, Diabetes, obesity & metabolism.

Polar lipid derangements in type 2 diabetes mellitus: potential pathological relevance of fatty acyl heterogeneity in sphingolipids

M. Wenk, G. Shui, R. Kelly, 2013, Metabolomics.

Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241–1249

T. Hardy, H. Fu, D. Moller, 2017, Diabetes Care.

Hemodynamic Effects of Acute Administration of Atomoxetine and Methylphenidate

R. Kelly, S. Lowe, S. Wise, 2005, Journal of clinical pharmacology.